CPHI 2026 Preview: Key Pharma Industry Trends to Watch

CPHI 2026 at a Glance Get ready for CPHI 2026. LucidQuest’s CPHI 2026 preview…


EURETINA 2026 preview covering retinal gene therapy, Eylea 8 mg, geographic atrophy treatments and AI in retinal imaging.

EURETINA 2026 Preview: Key Retinal Therapy Trends and Competitive Developments

Euretina 2026 at a glance At EURETINA 2026, retinal competition is increasingly…


EADV 2026_Preview_by_LucidQuest

EADV 2026 Preview: Emerging Dermatology Therapies and Competitive Trends

EADV 2026 at a glance At  2026,will differentiation in dermatology move beyond…


EASD 2026_Preview_by_LucidQuest

EASD 2026 Preview: Emerging Diabetes Therapies and Competitive Trends

EASD 2026 at a gance At EASD 2026, where will competition in diabetes and…


WCLC 2026 preview covering lung cancer treatment trends, antibody-drug conjugates, EGFR therapies, precision oncology and AI.

WCLC 2026 Preview: Emerging Lung Cancer Therapies and Competitive Trends

WCLC 2026 at a glance At IASLC-WCLC 2026, where will the next wave of…


ERS 2026 Preview: Respiratory Therapies and Competitive Trends

ERS 2026 at a glance Will respiratory treatment differentiation increasingly…


ESC Congress 2026 preview covering ATTR-CM, hypertrophic cardiomyopathy, Factor XI inhibitors, lipid-lowering therapies and AI in cardiology.

ESC 2026 Preview: Cardiovascular Therapies and Competitive Trends

ESC at a glance At ESC Congress 2026, how will earlier patient identification,…


EAN 2026_Preview_by_LucidQuest

EAN 2026 Preview: Competitive Shifts in Neurology

EAN 2026 at a glance EAN 2026 highlights a competitive shift in neurology…


ISTH 2026 preview highlighting competitive developments in hemophilia, von Willebrand disease, anticoagulation and AI diagnostics.

ISTH 2026 Preview: Hemophilia, VWD and Anticoagulation Market Trends

ISTH 2026 at a glance ISTH 2026 brings emerging competitive dynamics into focus…


NLA Sessions 2026 preview covering lipid management, cardiovascular prevention and emerging therapies.

NLA 2026 Preview: Competitive Shifts in Lipid Management

NLA 2026 at a glance NLA 2026 highlights a shift in lipid management from risk…


FSCDR 2026 conference preview on sickle cell disease therapies, clinical endpoints and gene therapy access.

FSCDR 2026 Preview: Competitive Shifts in Sickle Cell Disease

FSCDR 2026 at a glance FSCDR 2026 will examine how sickle cell disease (SCD)…


EULAR 2026 rheumatology conference preview covering emerging therapies, treatment sequencing and artificial intelligence.

EULAR 2026 Preview: Competitive Shifts in Rheumatology

EULAR 2026 at a glance EULAR 2026 highlights a potential shift in rheumatology…


Privacy Preference Center